University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System, Little Rock, AR 72212, USA.
Biochem Biophys Res Commun. 2013 Feb 15;431(3):496-500. doi: 10.1016/j.bbrc.2013.01.029. Epub 2013 Jan 16.
We observed uniform sustained Dil-ox-LDL uptake in macrophages in the presence or absence of ox-LDL receptor-1 (LOX-1). We wondered if the deficiency of LOX-1 modulates the expression of two other scavenger receptors, macrophage scavenger receptor-1 (MSR1) and CD36, on macrophages to account for the unaltered ox-LDL uptake. Macrophages were isolated from wild-type (WT) and LOX-1 knockout (KO) mice and stimulated with ox-LDL. Dil-ox-LDL uptake and expression of MSR1 and CD36 examined. Abrogation of LOX-1 did not significantly change Dil-ox-LDL uptake by macrophages. LOX-1 KO macrophages showed a significant decrease in CD36 at baseline as well as after ox-LDL stimulation and a marked almost 100% increase in the expression of MSR1, both at mRNA and protein levels (all p<0.05 vs. WT macrophages). Further, we observed a reduction in the expression of PPAR-γ in LOX-1 KO macrophages. To ascertain the role of PPAR-γ in the altered expression of MSR1 and CD36, LOX-1 KO macrophages were treated with troglitazone, a PPAR-γ agonist. Activation of PPAR-γ by troglitazone reversed the increased expression of MSR1 as well as the decreased expression of CD36 in LOX-1 KO macrophages. LOX-1 abrogation induces MSR1 and inhibits CD36 expression. The increase in MSR1 most likely accounts for sustained Dil-ox-LDL uptake despite LOX-1 abrogation. The alterations in CD36 and MSR1 occur through a decrease in PPAR-γ.
我们观察到在存在或不存在 ox-LDL 受体-1 (LOX-1) 的情况下,巨噬细胞中 Dil-ox-LDL 的摄取是一致的、持续的。我们想知道 LOX-1 的缺乏是否会调节巨噬细胞上另外两种清道夫受体,即巨噬细胞清道夫受体-1 (MSR1) 和 CD36 的表达,以解释 ox-LDL 摄取没有改变。从野生型 (WT) 和 LOX-1 敲除 (KO) 小鼠中分离巨噬细胞,并用 ox-LDL 刺激。检测 Dil-ox-LDL 的摄取和 MSR1 和 CD36 的表达。阻断 LOX-1 不会显著改变巨噬细胞对 Dil-ox-LDL 的摄取。LOX-1 KO 巨噬细胞在基线以及 ox-LDL 刺激后 CD36 的表达明显下降,同时 MSR1 的表达明显增加近 100%,mRNA 和蛋白水平均如此(与 WT 巨噬细胞相比,均为 p<0.05)。此外,我们观察到 LOX-1 KO 巨噬细胞中 PPAR-γ 的表达减少。为了确定 PPAR-γ 在 MSR1 和 CD36 表达改变中的作用,用 PPAR-γ 激动剂曲格列酮处理 LOX-1 KO 巨噬细胞。曲格列酮激活 PPAR-γ 逆转了 LOX-1 KO 巨噬细胞中 MSR1 表达的增加以及 CD36 表达的降低。LOX-1 的阻断诱导 MSR1 的表达增加并抑制 CD36 的表达。MSR1 的增加很可能是由于 LOX-1 阻断后 Dil-ox-LDL 的摄取持续增加。CD36 和 MSR1 的改变是通过 PPAR-γ 的减少发生的。